Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

By-Health Partners with Meituan’s Drug Purchase APP for New Retail Expansion

January 19, 2025
CompanyDeals

Kangtai Biological Partners with Pakistani Firm for Pneumonia Vaccine Expansion

January 19, 2025
CompanyDeals

Shanghai-Based REMD Raises Series A+ Funding for Electroporation Device Expansion

January 19, 2025
CompanyDrug

NMPA Approves Keverprazan for Duodenal Ulcers and Reflux Esophagitis

January 19, 2025
Company

Organon Reports Q4 and Full-Year 2022 Financials with Revenue Declines

January 19, 2025
CompanyDeals

WinHealth Pharma Taps Baidu’s ERNIE Bot for Rare Disease Services

January 19, 2025
Company

Eppendorf to Start Construction on New Shanghai Production Site

January 19, 2025
CompanyDeals

InnoCare Regains Rights to Orelabrutinib as Biogen Terminates Licensing Agreement

January 19, 2025
CompanyDrug

AIM Vaccine Gains Approvals for COVID-19 mRNA Vaccine Trials in Pakistan

January 19, 2025
CompanyDrug

Innovent Biologics Initiates Phase III CLEAR Study for Picankibart in Psoriasis

January 19, 2025
CompanyDrug

Frontera Therapeutics Initiates FT-002 Clinical Study for X-Linked Retinitis Pigmentosa

January 19, 2025
CompanyDrug

Kanghong’s KH617 Receives Orphan Drug Designation for Glioblastoma

January 19, 2025
1 2 … 7 8 9 10 11 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up